Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14)

What is Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14)?

Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 are two specific probiotic strains that were intentionally selected from healthy women's urogenital tracts because of their remarkable ability to survive the journey from the gut to the vagina and actually set up residence there. Unlike generic probiotic blends, this pairing was purpose-built for women's vaginal and urinary health, backed by decades of targeted clinical research. They are the most studied probiotic combination for urogenital conditions in women worldwide.

How does Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) work?

When taken orally, these strains travel through the digestive tract and migrate to the vaginal environment, where they produce lactic acid to keep the pH naturally acidic, hydrogen peroxide to crowd out harmful bacteria, and signaling compounds that discourage pathogens from sticking to vaginal walls. They essentially act as reinforcements for your body's own natural defense system, restoring the Lactobacillus-dominant environment that keeps the vagina healthy and self-regulating. A balanced vaginal microbiome is strongly linked to lower rates of BV, yeast overgrowth, and UTIs.

What forms does Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) come in?

The oral capsule is the most thoroughly studied and convenient form — the strains are capable of migrating from the gut to the vaginal tract. Each capsule typically contains at least 1 billion CFUs (colony-forming units) of each strain. Vaginal suppositories are also available and deliver the strains more directly, which may be useful for acute situations. Freeze-dried formats require refrigeration to maintain viability; some newer formulations use microencapsulation for room-temperature stability.

Where it comes from:

GR-1 was first isolated in the 1980s by Dr. Andrew Bruce and Dr. Gregor Reid at the University of Toronto from a healthy woman's urinary tract. RC-14 was similarly isolated from vaginal microbiota of a healthy woman. The decades-long collaboration between Reid and his team — including researchers at Lawson Health Research Institute in Canada and the University of Western Ontario — produced the foundational clinical evidence base that established these two strains as the gold standard for urogenital probiotic therapy. Their work demonstrated for the first time that oral probiotics could successfully colonize the vaginal environment.

What does Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) help with?

• Bacterial vaginosis (BV): BV happens when the normal Lactobacillus bacteria that keep the vagina healthy get outnumbered by a mix of other bacteria, causing odor, discharge, and discomfort. GR-1 and RC-14 directly address this by repopulating the vagina with protective Lactobacillus strains, restoring a healthy acidic environment that makes it harder for BV-associated bacteria to take hold. Multiple clinical trials show these strains significantly improve cure rates and reduce BV recurrence, especially when used alongside or after antibiotic treatment.
• Recurrent yeast infections (Candida): Women prone to recurrent yeast infections often have a disrupted vaginal microbiome that allows Candida to overgrow. By reestablishing a strong Lactobacillus presence and lowering vaginal pH, GR-1 and RC-14 make the environment less hospitable for yeast to flourish. Clinical evidence supports their use as a preventive tool, particularly for women who cycle through repeated antibiotic or antifungal courses.
• Urinary tract infections (UTIs): The same protective Lactobacillus environment that guards vaginal health also extends to the urethra and lower urinary tract, helping to block uropathogens like E. coli from gaining a foothold. GR-1 in particular has strong urinary tract adhesion properties and has been shown in clinical trials to reduce UTI recurrence in women who are prone to repeated infections.
• Vaginal pH imbalance: A healthy vaginal pH sits between 3.8 and 4.5 — naturally acidic thanks to Lactobacillus producing lactic acid. When pH rises (from sex, menstruation, antibiotics, or hormonal shifts), harmful bacteria thrive. GR-1 and RC-14 actively produce lactic acid to help restore and maintain this acidic balance, which is foundational to all aspects of vaginal health.
• Antibiotic-associated vaginal disruption: Antibiotics are notorious for wiping out beneficial vaginal bacteria along with the bacteria they are targeting, often triggering BV or yeast infections shortly after treatment. Taking GR-1 and RC-14 during and after antibiotic therapy helps restore vaginal flora more quickly and reduces the likelihood of these secondary infections developing.
• Aerobic vaginitis: Aerobic vaginitis is an inflammatory vaginal condition caused by overgrowth of aerobic bacteria like Staphylococcus aureus and E. coli rather than the anaerobic bacteria associated with BV. Emerging clinical evidence suggests GR-1 and RC-14 can help correct the underlying microbiome imbalance that drives this condition, reducing inflammation and recurrence.
• Vaginal microbiome imbalance: Even without a named diagnosis, many women experience ongoing discomfort, unusual discharge, or sensitivity that reflects a disrupted vaginal ecosystem. Daily use of these two strains helps normalize the microbial community, supporting the kind of stable, Lactobacillus-dominant environment associated with comfort and resilience.
• Postmenopausal vaginal health: After menopause, declining estrogen leads to a natural shift in vaginal microbiota and pH, often resulting in dryness, irritation, and increased susceptibility to infections. Supplementing with GR-1 and RC-14 has shown promise in helping perimenopausal and postmenopausal women maintain a more balanced vaginal environment, complementing other approaches like topical estrogen.
• Group B Strep colonization (pregnancy): Group B Streptococcus (GBS) colonization in the vagina during late pregnancy is a concern for newborn health. Preliminary clinical evidence suggests that GR-1 and RC-14 supplementation during pregnancy may help reduce GBS vaginal colonization, though this area is still being actively researched and should always be discussed with an OB or midwife.
• Vulvovaginal discomfort and odor: Persistent vaginal odor and irritation are often signs of microbiome imbalance rather than a formal infection. By restoring a healthy, lactic-acid-producing bacterial community, GR-1 and RC-14 address the root cause of these symptoms rather than just masking them, offering lasting relief for women who experience these issues chronically.

What can Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) help prevent?

• Recurrent bacterial vaginosis after antibiotic treatment
• Recurrent urinary tract infections in women with a history of frequent UTIs
• Antibiotic-induced vaginal dysbiosis
• Yeast overgrowth following antibiotic courses

Which foods are rich in Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14)?

1. Plain whole-milk yogurt (with live active cultures): Contains live Lactobacillus strains that support a Lactobacillus-dominant gut and vaginal environment — not identical strains, but a meaningful daily reinforcement of the broader lactobacillus ecosystem.
2. Kefir: A fermented dairy drink with a diverse and dense colony of live Lactobacillus and other beneficial bacteria — one of the richest food-based probiotic sources available and well studied for microbiome support.
3. Fermented vegetables (sauerkraut, kimchi: unpasteurized) — Unpasteurized fermented vegetables contain live Lactobacillus species that contribute to overall gut microbiome diversity, which indirectly supports the broader microbial balance linked to vaginal health.
4. Prebiotic-rich foods (garlic, onion, leeks, asparagus, bananas) — Prebiotics feed and sustain beneficial Lactobacillus bacteria already in the gut, helping GR-1 and RC-14 establish and maintain colonies more effectively — think of them as fertilizer for your probiotic investment.
5. Miso and tempeh: Fermented soy foods contribute beneficial bacteria and support a gut environment favorable to Lactobacillus colonization, complementing oral probiotic supplementation.

What are the side effects of Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14)?

• Mild bloating or gas in the first 1–2 weeks as gut microbiome adjusts
• Temporary changes in vaginal discharge as flora shifts: usually brief
• Very rarely, mild digestive upset in sensitive individuals
• Theoretical infection risk in severely immunocompromised individuals (no reported cases with these strains)
• Possible temporary increase in vaginal discomfort in the first week as the microbiome rebalances

Good to know:

GR-1 and RC-14 have an excellent safety profile and have been used in clinical trials spanning decades with no serious adverse events reported. They are considered safe for most women including during pregnancy, though anyone pregnant should consult their provider.

How much Probiotics (Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14) should you take?

• Recommended daily: 1 capsule daily providing at least 1 billion CFU (1 × 10⁹ CFU) each of L. rhamnosus GR-1 and L. reuteri RC-14 — the dosage used in the majority of clinical trials. Most commercial products (e.g., Fem-Dophilus) provide this exact amount.
• Best time of day: Evening or bedtime is often recommended — taking probiotics before sleep gives the strains more time in a resting digestive tract to survive and migrate effectively. Consistency matters more than exact timing.
• With or without food: Can be taken with or without food. Taking with a small meal or glass of milk may offer mild buffering against stomach acid, slightly improving strain survival — though GR-1 and RC-14 are among the more acid-resistant probiotic strains studied.
• Time to effect: Vaginal flora changes are measurable within 1–2 weeks; meaningful symptom improvement and colonization typically established by 4–8 weeks of daily use. For prevention of recurrence, ongoing daily use is recommended.
• How long to take it: For active BV or UTI prevention: use daily for a minimum of 8–12 weeks, then reassess. For long-term maintenance and recurrence prevention: ongoing daily use is well-supported by clinical evidence. During and after antibiotic courses: start immediately and continue for at least 4 weeks post-antibiotic. No cycling required — these strains are safe for continuous use.